{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:54:40Z","timestamp":1786982080423,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"General Research Project of Zhejiang Provincial Department of Education","award":["No.Y202249323"],"award-info":[{"award-number":["No.Y202249323"]}]},{"name":"General Project of Zhejiang Province Medical and Health Science and Technology Programme","award":["No. 2024KY672"],"award-info":[{"award-number":["No. 2024KY672"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s11695-024-07139-y","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T11:02:47Z","timestamp":1709290967000},"page":"1333-1342","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["TyG-GGT is a Reliable Non-Invasive Predictor of Advanced Liver Fibrosis in Overweight or Obese Individuals"],"prefix":"10.1007","volume":"34","author":[{"given":"Lei","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Fei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei-Qi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Kun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Yu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Qing","family":"Ru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Dong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8521-4248","authenticated-orcid":false,"given":"Zun-Qiang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,1]]},"reference":[{"issue":"4","key":"7139_CR1","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1001\/jamasurg.2022.7989","volume":"158","author":"ZJ Brown","year":"2023","unstructured":"Brown ZJ, Tsilimigras DI, Ruff SM, et al. Management of hepatocellular carcinoma: a review. JAMA Surg. 2023;158(4):410\u201320.","journal-title":"JAMA Surg"},{"issue":"251","key":"7139_CR2","doi-asserted-by":"publisher","first-page":"126263","DOI":"10.1016\/j.ijbiomac.2023.126263","volume":"9","author":"R Gui","year":"2023","unstructured":"Gui R, Li W, Li Z, et al. Effects and potential mechanisms of IGF1\/IGF1R in the liver fibrosis: A review. Int J Biol Macromol. 2023;9(251):126263.","journal-title":"Int J Biol Macromol"},{"issue":"5","key":"7139_CR3","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/hep.27368","volume":"61","author":"M Ekstedt","year":"2015","unstructured":"Ekstedt M, Hagstr\u00f6m H, Nasr P, et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology. 2015;61(5):1547\u201354.","journal-title":"Hepatology"},{"key":"7139_CR4","unstructured":"World Obesity Federation, World Obesity Atlas. 2023. https:\/\/data.worldobesity.org\/publications\/?cat=19."},{"issue":"11","key":"7139_CR5","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","volume":"10","author":"R Loomba","year":"2013","unstructured":"Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol. 2013;10(11):686\u201390.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"7139_CR6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","volume":"4","author":"J Li","year":"2019","unstructured":"Li J, Zou B, Yeo YH, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999\u20132019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2019;4(5):389\u201398.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"22","key":"7139_CR7","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1001\/jama.2015.5370","volume":"313","author":"ME Rinella","year":"2015","unstructured":"Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA. 2015;313(22):2263\u201373.","journal-title":"JAMA"},{"issue":"12","key":"7139_CR8","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jama.2020.2298","volume":"323","author":"AC Sheka","year":"2020","unstructured":"Sheka AC, Adeyi O, Thompson J, et al. Nonalcoholic steatohepatitis: a review. JAMA. 2020;323(12):1175\u201383.","journal-title":"JAMA"},{"key":"7139_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.metabol.2016.12.006","volume":"68","author":"CN Katsagoni","year":"2017","unstructured":"Katsagoni CN, Georgoulis M, Papatheodoridis GV, et al. Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis. Metabolism. 2017;68:119\u201332.","journal-title":"Metabolism"},{"issue":"5","key":"7139_CR10","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","volume":"156","author":"L Castera","year":"2019","unstructured":"Castera L, Friedrich-Rust M, Loomba R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(5):1264-1281.e4.","journal-title":"Gastroenterology"},{"issue":"2","key":"7139_CR11","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jhep.2023.04.002","volume":"79","author":"M Kjaergaard","year":"2023","unstructured":"Kjaergaard M, Lindvig KP, Thorhauge KH, et al. Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease. J Hepatol. 2023;79(2):277\u201386.","journal-title":"J Hepatol"},{"issue":"1","key":"7139_CR12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1186\/s12876-021-02038-3","volume":"21","author":"B Amernia","year":"2021","unstructured":"Amernia B, Moosavy SH, Banookh F, et al. FIB-4, APRI, and AST\/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas. Iran BMC Gastroenterol. 2021;21(1):453.","journal-title":"Iran BMC Gastroenterol"},{"issue":"16","key":"7139_CR13","doi-asserted-by":"publisher","first-page":"4910","DOI":"10.3390\/jcm11164910","volume":"11","author":"ECS Sandvik","year":"2022","unstructured":"Sandvik ECS, Aasar\u00f8d KM, Johnsen G, et al. The effect of roux-en-Y gastric bypass on non-alcoholic fatty liver disease fibrosis assessed by FIB-4 and NFS scores-An 11.6-year follow-up study. J Clin Med. 2022;11(16):4910.","journal-title":"J Clin Med."},{"issue":"4","key":"7139_CR14","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3350\/cmh.2022.0099","volume":"28","author":"JH Lee","year":"2022","unstructured":"Lee JH, Park K, Lee HS, et al. The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults. Clin Mol Hepatol. 2022;28(4):814\u201326.","journal-title":"Clin Mol Hepatol"},{"issue":"22","key":"7139_CR15","doi-asserted-by":"publisher","first-page":"e7041","DOI":"10.1097\/MD.0000000000007041","volume":"96","author":"S Zhang","year":"2017","unstructured":"Zhang S, Du T, Li M, et al. Triglyceride glucose-body mass index is effective in identifying nonalcoholic fatty liver disease in nonobese subjects. Medicine (Baltimore). 2017;96(22):e7041.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"7139_CR16","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12944-020-01393-6","volume":"19","author":"W Guo","year":"2020","unstructured":"Guo W, Lu J, Qin P, et al. The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease: a cross-sectional study in Chinese adults. Lipids Health Dis. 2020;19(1):218.","journal-title":"Lipids Health Dis"},{"issue":"8","key":"7139_CR17","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. 2016;65(8):1038\u201348.","journal-title":"Metabolism"},{"issue":"4","key":"7139_CR18","doi-asserted-by":"publisher","first-page":"101345","DOI":"10.1016\/j.diabet.2022.101345","volume":"48","author":"B Rivi\u00e8re","year":"2022","unstructured":"Rivi\u00e8re B, Jaussent A, Macioce V, et al. The triglycerides and glucose (TyG) index: A new marker associated with nonalcoholic steatohepatitis (NASH) in obese patients. Diabetes Metab. 2022;48(4):101345.","journal-title":"Diabetes Metab"},{"issue":"6","key":"7139_CR19","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313\u201321.","journal-title":"Hepatology"},{"issue":"3","key":"7139_CR20","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/hep.24127","volume":"53","author":"EM Brunt","year":"2011","unstructured":"Brunt EM, Kleiner DE, Wilson LA, et al. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology. 2011;53(3):810\u201320.","journal-title":"Hepatology"},{"issue":"10","key":"7139_CR21","doi-asserted-by":"publisher","first-page":"e1912565","DOI":"10.1001\/jamanetworkopen.2019.12565","volume":"2","author":"DE Kleiner","year":"2019","unstructured":"Kleiner DE, Brunt EM, Wilson LA, et al. Association of histologic disease activity with progression of nonalcoholic fatty liver disease. JAMA Netw Open. 2019;2(10):e1912565.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"7139_CR22","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","volume":"79","author":"VW Wong","year":"2023","unstructured":"Wong VW, Ekstedt M, Wong GL, et al. Changing epidemiology, global trends and implications for outcomes of NAFLD. J Hepatol. 2023;79(3):842\u201352.","journal-title":"J Hepatol"},{"key":"7139_CR23","doi-asserted-by":"publisher","first-page":"113869","DOI":"10.1016\/j.addr.2021.113869","volume":"176","author":"S Kumar","year":"2021","unstructured":"Kumar S, Duan Q, Wu R, et al. Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis. Adv Drug Deliv Rev. 2021;176:113869.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"7139_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","volume":"8","author":"J Quek","year":"2023","unstructured":"Quek J, Chan KE, Wong ZY, et al. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023;8(1):20\u201330.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"7139_CR25","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1002\/hep.31845","volume":"74","author":"TG Simon","year":"2021","unstructured":"Simon TG, Roelstraete B, Sharma R, et al. Cancer risk in patients with biopsy-confirmed nonalcoholic fatty liver disease: a population-based cohort study. Hepatology. 2021;74(5):2410\u201323.","journal-title":"Hepatology"},{"issue":"3","key":"7139_CR26","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1148\/radiol.2018170601","volume":"286","author":"P Kennedy","year":"2018","unstructured":"Kennedy P, Wagner M, Cast\u00e9ra L, et al. Quantitative elastography methods in liver disease: current evidence and future directions. Radiology. 2018;286(3):738\u201363.","journal-title":"Radiology"},{"issue":"Suppl","key":"7139_CR27","doi-asserted-by":"publisher","first-page":"S136","DOI":"10.3350\/cmh.2022.0436","volume":"29","author":"JH Yu","year":"2023","unstructured":"Yu JH, Lee HA, Kim SU. Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future. Clin Mol Hepatol. 2023;29(Suppl):S136\u201349.","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"7139_CR28","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/hep.32358","volume":"76","author":"R Pais","year":"2022","unstructured":"Pais R, Aron-Wisnewsky J, Bedossa P, et al. Persistence of severe liver fibrosis despite substantial weight loss with bariatric surgery. Hepatology. 2022;76(2):456\u201368.","journal-title":"Hepatology"},{"issue":"14","key":"7139_CR29","doi-asserted-by":"publisher","first-page":"1090598","DOI":"10.3389\/fendo.2023.1090598","volume":"30","author":"Y Huang","year":"2023","unstructured":"Huang Y, Dong S, Wang C, et al. Significant fibrosis assessed by liver biopsy among Chinese bariatric surgery patients: A prospective cross-sectional study. Front Endocrinol (Lausanne). 2023;30(14):1090598.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"7139_CR30","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jhep.2022.11.010","volume":"78","author":"V Ajmera","year":"2023","unstructured":"Ajmera V, Cepin S, Tesfai K, et al. A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes. J Hepatol. 2023;78(3):471\u20138.","journal-title":"J Hepatol"},{"issue":"1","key":"7139_CR31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12916-019-1321-x","volume":"17","author":"M Alexander","year":"2019","unstructured":"Alexander M, Loomis AK, van der Lei J, et al. Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts. BMC Med. 2019;17(1):95.","journal-title":"BMC Med"},{"issue":"9","key":"7139_CR32","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.2337\/db22-0933","volume":"72","author":"S Sako","year":"2023","unstructured":"Sako S, Takeshita Y, Takayama H, et al. Trajectories of liver fibrosis and gene expression profiles in nonalcoholic fatty liver disease associated with diabetes. Diabetes. 2023;72(9):1297\u2013306.","journal-title":"Diabetes"},{"issue":"1","key":"7139_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4093\/dmj.2021.0280","volume":"46","author":"SH Lee","year":"2022","unstructured":"Lee SH, Park SY, Choi CS. Insulin resistance: from mechanisms to therapeutic strategies. Diabetes Metab J. 2022;46(1):15\u201337.","journal-title":"Diabetes Metab J"},{"issue":"2","key":"7139_CR34","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1055\/s-0035-1550065","volume":"35","author":"P Angulo","year":"2015","unstructured":"Angulo P, Machado MV, Diehl AM. Fibrosis in nonalcoholic Fatty liver disease: mechanisms and clinical implications. Semin Liver Dis. 2015;35(2):132\u201345.","journal-title":"Semin Liver Dis"},{"issue":"1","key":"7139_CR35","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/ije\/dyz053","volume":"49","author":"J Fritz","year":"2020","unstructured":"Fritz J, Bj\u00f8rge T, Nagel G, et al. The triglyceride-glucose index as a measure of insulin resistance and risk of obesity-related cancers. Int J Epidemiol. 2020;49(1):193\u2013204.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"7139_CR36","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jhep.2005.06.018","volume":"44","author":"A Lonardo","year":"2006","unstructured":"Lonardo A, Lombardini S, Scaglioni F, et al. Hepatic steatosis and insulin resistance: does etiology make a difference? J Hepatol. 2006;44(1):190\u20136.","journal-title":"J Hepatol"},{"issue":"14","key":"7139_CR37","doi-asserted-by":"crossref","first-page":"175628482110106","DOI":"10.1177\/17562848211010675","volume":"29","author":"DW Zeng","year":"2021","unstructured":"Zeng DW, Huang ZX, Lin MX, et al. A novel HBsAg-based model for predicting significant liver fibrosis among Chinese patients with immune-tolerant phase chronic hepatitis B: a multicenter retrospective study. Therap Adv Gastroenterol. 2021;29(14):17562848211010676.","journal-title":"Therap Adv Gastroenterol"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-024-07139-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-024-07139-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-024-07139-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T10:16:46Z","timestamp":1713435406000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-024-07139-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["7139"],"URL":"https:\/\/doi.org\/10.1007\/s11695-024-07139-y","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,1]]},"assertion":[{"value":"30 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The ethics involved in this study have been approved by the Ethics Committee of Zhejiang Provincial People's Hospital. (QT2024003).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"No conflict of interest exist for all authors in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Role of the Funder\/Sponsor"}}]}}